Skip to main contentSkip to navigationSkip to search

ENDO 2026

Long-term safety and efficacy of CAM2029 in patients with acromegaly: results from the ACROINNOVA 2 open-label extension

Click the material you wish to view

ACROINNOVA 2 extension

Pdf 0.5 MB

ACROINNOVA 2 extension supplementary

pdf 1.2 MB

See all posters presented at
ENDO 2026

Explore more

Disease areas

Orci tempus mi proin est libero mi eget ut pellentesque.

Congresses

Ac purus quam sollicitudin eget. Dignissim quisque cursus elit eget tellus nunc luctus fringilla adipiscing.